Candid Therapeutics
ClosedRewriting the Biology of Autoimmune Disease
San Diego, United States · Founded 2024 · $875.0M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2024
- Business Model
- B2B
- Website
- candidtx.com
- Total Funding
- $875.0M
- Last Round
- $505.0M Venture RoundMar 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Candid Therapeutics is a clinical-stage biopharmaceutical company developing bispecific antibody therapies for autoimmune and inflammatory diseases. Founded in 2023 and backed by $370M in funding, the company is building a pipeline of next-generation immunology treatments targeting unmet medical needs in conditions such as lupus and myasthenia gravis.
Summary
Candid Therapeutics is a Biotech company based in San Diego, United States, founded in 2024. It has raised $875.0M in total across 2 rounds, most recently a $505.0M Venture Round in Mar 2026.
Funding & Exit History
Mar 2026
Sign up to see all 3 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/candid-therapeutics"><img src="https://indexed.vc/api/badge/company/candid-therapeutics" alt="Candid Therapeutics on Indexed.vc" width="260" height="76" /></a>